International
-
Singing is no more risky than talking finds new COVID-19 study 20 August 2020 The performing arts has been badly affected during the coronavirus pandemic with live musical performances cancelled for many months because singing was identified as a potential "higher risk" activity. New collaborative research has shown that singing does not produce very substantially more respiratory particles than when speaking at a similar volume. The findings, published on the pre-print server ChemRxiv, are crucial in providing COVID-19 guidance for live musical performances and the safe distancing of performers and audience.
-
SETsquared Bristol awards six BAME-led startups with Breakthrough Bursary 18 December 2020 The University of Bristol’s world-leading tech incubator, SETsquared Bristol, is proud to announce six BAME-led companies that have been awarded their 2020 Breakthrough Bursary.
-
New technology enables ultra-fast steering and shaping of light beams 6 January 2015 A team of engineers has developed a new acousto-optic device that can shape and steer beams of light at speeds never before achieved. The new technology will enable better optical devices to be made, such as holographs that can move rapidly in real time.
-
New treatment offers hope for headshaking in horses 6 January 2015 At present there are no consistently safe and effective methods for the treatment of headshaking in horses. The condition, a neuropathic facial pain syndrome, often leaves affected horses impossible to ride and dangerous to handle, and can result in euthanasia. A new study has found a treatment called percutaneous electrical nerve stimulation (PENS) could reduce signs of the condition in horses. The same PENS therapy is used in people to manage neuropathic pain.
-
Cancer risk from obesity differs for men and women 17 December 2020 A new study, led by researchers at the University of Bristol and the International Agency for Research on Cancer (IARC), has revealed that where fat is on our body may lead to different health outcomes for men and women. The research, co-funded by World Cancer Research Fund (WCRF), Cancer Research UK and Diabetes UK, found that having more body fat around your waist is more dangerous for women than it is for men when it comes to risk of developing colorectal cancer (also known as bowel cancer).
-
Needle and syringe programmes are highly cost-effective at preventing hepatitis C transmission 24 January 2019 Providing clean injecting equipment through needle and syringe programmes is a highly cost-effective way of preventing hepatitis C (HCV) transmission among people who inject drugs and could save millions of pounds in infection treatment costs in the UK, according to research led by the University of Bristol and London School of Hygiene & Tropical Medicine.
-
UK Government announces £138 million funding for world-class infrastructure research 9 December 2015 Inadequate infrastructure costs the nation £2 million a day, and extreme events can cost hundreds of millions more. The University of Bristol is one of 14 university partners in the UK Collaboratorium for Research in Infrastructure and Cities (UKCRIC), which has secured £138 million of funding, to be match funded from other sources, as part of the UK Government’s spending review to develop a world-class, UK-based national infrastructure research community.
-
Global study finds high success rate for hip and knee replacements 14 February 2019 After reviewing thousands of case studies going back 25 years across six countries, generalisable survival data is now available for the first time to estimate how long hip and knee replacements are likely to last.
-
Vaccines must prevent infection, disease progression and transmission – in every country - to truly bring COVID-19 under control 15 December 2020 An editorial co-authored by a member of the UK's influential SAGE committee that advises the UK Government on COVID-19, and published in Anaesthesia (a journal of the Association of Anaesthetists) says that in order for the global COVID-19 vaccination program to be successful, the available vaccines must be able to do all three of: prevent infection becoming established in an individual, prevent disease progression and prevent onward transmission.
-
Researchers extend recruitment to COVID-19 vaccine trial 19 August 2020 Researchers at University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), North Bristol NHS Trust (NBT) and the University of Bristol have begun a new round of recruitment to a clinical trial of a vaccine pioneered in the UK which could protect against COVID-19.
View the for public events and lectures run by the University.